Colorado Department of Transportation crews are racing to complete rockfall mitigation and replace a retaining wall on U.S.

GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning. The fast ...